1. Home
  2. Adhesion to host cell membrane microdomains in cornea as an antimicrobial target to prevent corneal ulceration
DEPARTMENT FOR BUSINESS, ENERGY & INDUSTRIAL STRATEGY

Adhesion to host cell membrane microdomains in cornea as an antimicrobial target to prevent corneal ulceration

IATI Identifier: GB-GOV-13-FUND--GCRF-MR_S004688_1
Project disclaimer
Disclaimer: The data for this page has been produced from IATI data published by DEPARTMENT FOR BUSINESS, ENERGY & INDUSTRIAL STRATEGY. Please contact them (Show Email Address) if you have any questions about their data.

Description

All over the world, there is a growing problem with antibiotics: there have been years of misuse by patients, doctors and even farmers seeking greater yields from livestock, with the result that microbes have learned to live with these once potent drugs. This problem is particularly acute in India, where access to professional healthcare is often limited and so ineffective antibiotics are bought and used by patients. For agricultural and domestic labourers, minor damage to the surface of the eye frequently results in bacterial and fungal infections; when not properly treated, this can lead to corneal ulceration and, eventually, to blindness. In a working-age person, the economic consequences can be disastrous for them and thier families. Given these issues, we are now looking for an alternative route to protect eyes against microbes. We have formed a partnership with a leading eye hospital, LV Prasad Eye Institute. LVPEI have developed a pyramidal structure so that research developed in the advanced research and surgery centre in Hyderabad can rapidly be disseminated throughout their organisation. They have a major drive to develop therapies that can benefit patients in rural villages. The approach that we have taken came originally from a study of how our cells stick together to form tissues such as skin. There are structures on the surfaces of cells that resemble Velcro, highly organised patches of adhesive molecules that enable cells to cling tightly together. In some cases, these are long-lasting and static; in other cases they are short-lived and dynamic, allowing mobility, for instance when our white blood cells are travelling through tissues to get to the site of an infection. We discovered that some types of bacteria and yeasts can 'hijack' the dynamic sites, to allow them to stick to our tissues even when our natural defences try to dislodge them with tears and blinking. This is the starting point of an infection, when a colony of microorganisms attaches and starts to grow, often then penetrating deeper into tissues to cause serious disease. Even superficial infections can cause problems, leading to ulceration of the surface of the eye and eventually blindness if not properly treated. Different types of microbes use different types of human molecules to cling to: targeting all of them would be very expensive. Our approach is not to target the molecular hooks themselves, but the material in which they are held to form the sticky patches. On Velcro, hooks are embedded in a baselayer of woven material but on our cells this is formed by a sort of molecular raft called a microdomain. We have discovered how to weaken one type of microdomain, in a way that is analagous to stretching Velcro, pulling the molecular hooks further apart and significantly lowering the stickiness of the patches on cells. By addressing only one type of microdomain, we have found that we do not affect the normal behaviour of our cells but we do make bacteria and fungi much easier to wash away. Unlike antibiotics that directly target microbes, our treatment targets human cells and so should not lead to new forms of antibiotic resistance. If we can show that it is both safe and effective on the types of microbes that cause eye infections in India, we aim to produce a cheap and simple treatment for people who have injured their eyes, or who have early stage infections. This could be administered by patients or by a network of trained volunteers, easily and quickly. By helping to prevent infection, or giving more time to seek professional diagnosis, we hope to reduce the rate of a common cause of blindness in young people in India.

Objectives

The Global Challenges Research Fund (GCRF) supports cutting-edge research to address challenges faced by developing countries. The fund addresses the UN sustainable development goals. It aims to maximise the impact of research and innovation to improve lives and opportunity in the developing world.


Location

The country, countries or regions that benefit from this Programme.
India
Disclaimer: Country borders do not necessarily reflect the UK Government's official position.

Status Post-completion

The current stage of the Programme, consistent with the International Aid Transparency Initiative's (IATI) classifications.

Programme Spend

Programme budget and spend to date, as per the amounts loaded in financial system(s), and for which procurement has been finalised.

Participating Organisation(s)

Help with participating organisations

Accountable:Organisation responsible for oversight of the activity

Extending: Organisation that manages the budget on behalf of the funding organisation.

Funding: Organisation which provides funds.

Implementing: Organisations implementing the activity.

Sectors

Sector groups as a percentage of total Programme budget according to the OECD Development Assistance Committee (DAC) classifications.

Budget

A comparison across financial years of forecast budget and spend to date on the Programme.

Download IATI Data for GB-GOV-13-FUND--GCRF-MR_S004688_1